Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Clinical trial NCT00320788 · COMPLETED
Trial details
- NCT number
- NCT00320788
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2008-06-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.